These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 16179636)
1. Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). White ES; Atrasz RG; Hu B; Phan SH; Stambolic V; Mak TW; Hogaboam CM; Flaherty KR; Martinez FJ; Kontos CD; Toews GB Am J Respir Crit Care Med; 2006 Jan; 173(1):112-21. PubMed ID: 16179636 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration. Fagone E; Conte E; Gili E; Fruciano M; Pistorio MP; Lo Furno D; Giuffrida R; Crimi N; Vancheri C Exp Lung Res; 2011 Apr; 37(3):162-74. PubMed ID: 21269063 [TBL] [Abstract][Full Text] [Related]
3. Heat Shock Protein 27 Plays a Pivotal Role in Myofibroblast Differentiation and in the Development of Bleomycin-Induced Pulmonary Fibrosis. Park AM; Kanai K; Itoh T; Sato T; Tsukui T; Inagaki Y; Selman M; Matsushima K; Yoshie O PLoS One; 2016; 11(2):e0148998. PubMed ID: 26859835 [TBL] [Abstract][Full Text] [Related]
4. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways. Tumelty KE; Smith BD; Nugent MA; Layne MD J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132 [TBL] [Abstract][Full Text] [Related]
6. Phosphatase and tensin homolog deleted on chromosome 10 contributes to phenotype transformation of fibroblasts in idiopathic pulmonary fibrosis via multiple pathways. Geng J; Huang X; Li Y; Xu X; Li S; Jiang D; Liu Z; Dai H Exp Biol Med (Maywood); 2016 Jan; 241(2):157-65. PubMed ID: 26264443 [TBL] [Abstract][Full Text] [Related]
7. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Zhang HY; Gharaee-Kermani M; Zhang K; Karmiol S; Phan SH Am J Pathol; 1996 Feb; 148(2):527-37. PubMed ID: 8579115 [TBL] [Abstract][Full Text] [Related]
8. Effects of the tumor suppressor PTEN on the pathogenesis of idiopathic pulmonary fibrosis in Chinese patients. Xie B; Zheng G; Li H; Yao X; Hong R; Li R; Yue W; Chen Y Mol Med Rep; 2016 Mar; 13(3):2715-23. PubMed ID: 26846484 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts. Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294 [TBL] [Abstract][Full Text] [Related]
10. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis. Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178 [TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Shukla MN; Rose JL; Ray R; Lathrop KL; Ray A; Ray P Am J Respir Cell Mol Biol; 2009 Jun; 40(6):643-53. PubMed ID: 18988920 [TBL] [Abstract][Full Text] [Related]
12. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. Pechkovsky DV; Prêle CM; Wong J; Hogaboam CM; McAnulty RJ; Laurent GJ; Zhang SS; Selman M; Mutsaers SE; Knight DA Am J Pathol; 2012 Apr; 180(4):1398-412. PubMed ID: 22322297 [TBL] [Abstract][Full Text] [Related]
13. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis. Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065 [TBL] [Abstract][Full Text] [Related]
14. Antifibrotic effects of focal adhesion kinase inhibitor in bleomycin-induced pulmonary fibrosis in mice. Kinoshita K; Aono Y; Azuma M; Kishi J; Takezaki A; Kishi M; Makino H; Okazaki H; Uehara H; Izumi K; Sone S; Nishioka Y Am J Respir Cell Mol Biol; 2013 Oct; 49(4):536-43. PubMed ID: 23642017 [TBL] [Abstract][Full Text] [Related]
16. Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis. Liu T; Warburton RR; Guevara OE; Hill NS; Fanburg BL; Gaestel M; Kayyali US Am J Respir Cell Mol Biol; 2007 Nov; 37(5):507-17. PubMed ID: 17600313 [TBL] [Abstract][Full Text] [Related]
17. Role of miR-145 in cardiac myofibroblast differentiation. Wang YS; Li SH; Guo J; Mihic A; Wu J; Sun L; Davis K; Weisel RD; Li RK J Mol Cell Cardiol; 2014 Jan; 66():94-105. PubMed ID: 24001939 [TBL] [Abstract][Full Text] [Related]
18. Involvement of serum response factor isoforms in myofibroblast differentiation during bleomycin-induced lung injury. Yang Y; Zhe X; Phan SH; Ullenbruch M; Schuger L Am J Respir Cell Mol Biol; 2003 Nov; 29(5):583-90. PubMed ID: 12777247 [TBL] [Abstract][Full Text] [Related]
19. Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo. Kuse N; Kamio K; Azuma A; Matsuda K; Inomata M; Usuki J; Morinaga A; Tanaka T; Kashiwada T; Atsumi K; Hayashi H; Saito Y; Seike M; Gemma A J Nippon Med Sch; 2020 Jul; 87(3):118-128. PubMed ID: 31776321 [TBL] [Abstract][Full Text] [Related]
20. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype. Epstein Shochet G; Wollin L; Shitrit D Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]